Skip to main navigation Skip to search Skip to main content

Unlocking the Therapeutic Potential of Ganoderma lucidum: From Bioactive Compounds to Clinical Translation

  • Gadallah MOHAMED
  • , Zhixin SUN
  • , Lifan YU
  • , Adam JUNKA
  • , Ruixin BEI
  • , Gautam SETHI
  • , Mingzhe YU
  • , Yanfang SUN*
  • *Corresponding author for this work

Research output: Journal Publications › Review article › Other Review

Abstract

Ganoderma lucidum, a revered medicinal mushroom with a rich history in traditional East Asian medicine, has garnered significant scientific attention for its diverse pharmacological properties. This comprehensive review synthesises recent advancements in understanding the phytochemistry, biological activities and therapeutic applications of G. lucidum. We delve into the intricate composition of its bioactive compounds, including polysaccharides, triterpenoids, sterols and phenolic compounds, elucidating their mechanisms of action in immunomodulation, anti-inflammatory responses, antioxidant defence, hepatoprotection and anticancer potential. Furthermore, this review examines emerging applications in nanotechnology, where G. lucidum extracts are utilised for the green synthesis of nanoparticles and as components in advanced drug delivery systems, antimicrobial nanomaterials and biosensors. We also discuss its expanding role in nutraceuticals, functional foods and cosmeceuticals, highlighting its anti-aging, skin-brightening and calming properties. Finally, the safety profile and toxicological evaluations of G. lucidum are critically assessed, alongside its growing economic significance. This review underscores the immense therapeutic potential of G. lucidum as a natural resource for modern medicine and biotechnology, while also identifying key challenges and future directions for research to facilitate its broader clinical and industrial translation.

Original languageEnglish
Pages (from-to)4532-4555
Number of pages24
JournalPhytotherapy Research
Volume40
Issue number7
Early online date11 May 2026
DOIs
Publication statusPublished - Jul 2026

Bibliographical note

Publisher Copyright:
© 2026 John Wiley & Sons Ltd.

Funding

This research was funded by Zhejiang Province ‘Spearhead’ and ‘Leading Wild Goose’ Research and Development Project of Bilateral Industrial Joint Research and Development Plan (2023C04046).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • bioactive metabolites
  • functional foods
  • Ganoderma lucidum
  • immunopharmacology
  • nanobiotechnology
  • oncological therapeutics
  • pharmacological potential

Fingerprint

Dive into the research topics of 'Unlocking the Therapeutic Potential of Ganoderma lucidum: From Bioactive Compounds to Clinical Translation'. Together they form a unique fingerprint.

Cite this